TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Shire Biotech Norway AS
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
16,012
|
11,141
|
9,414 |
Financial expenses |
20
|
-2
|
30 |
Earnings before taxes |
763
|
532
|
420 |
Total assets |
5,055
|
3,891
|
2,431 |
Current assets |
5,041
|
3,867
|
2,429 |
Current liabilities |
3,258
|
2,677
|
1,498 |
Equity capital |
1,797
|
1,214
|
932 |
- share capital |
82
|
78
|
82 |
Employees (average) |
6
|
5
![]() |
5 |
Shareholders | 0 | 0 | 3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
35.5%
|
31.2%
|
38.3% |
Turnover per employee |
2,669
|
2,228
|
1,883 |
Profit as a percentage of turnover |
4.8%
![]() |
4.8%
|
4.5% |
Return on assets (ROA) |
15.5%
|
13.6%
|
18.5% |
Current ratio |
154.7%
|
144.5%
|
162.1% |
Return on equity (ROE) |
42.5%
|
43.8%
|
45.1% |
Change turnover |
4,335
|
2,210
|
4,689 |
Change turnover % |
37%
|
25%
|
99% |
Chg. No. of employees |
1
|
0
|
2 |
Chg. No. of employees % |
20%
|
0%
|
67% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.